Jiangsu Recbio Nominates Jiang Chunyan as Executive Director

PUBT · 2d ago
Jiangsu Recbio Nominates Jiang Chunyan as Executive Director
  • Jiangsu Recbio Technology nominated Jiang Chunyan as executive director on November 18, 2026, subject to shareholder approval.
  • Her directorship would run from shareholder approval until the second board session's term expires, with eligibility for reelection.
  • Jiang became joint company secretary effective November 18, 2026.
  • She also replaced Wang Ruwei as authorized representative effective the same date.
  • Jiang heads the board office and previously held management roles at Yangtze River Pharmaceutical, with 17 years of pharmaceutical manufacturing experience.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangsu Recbio Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261118-12417913), on November 18, 2026, and is solely responsible for the information contained therein.